News
Watch
Expert Conversations
Shows & Podcasts
News & Analysis
Conferences
Partners
More
Publications
All Publications
MHE Publication
Formulary Watch Supplements
Formulary Watch Spotlights
Supplements And Featured Publications
Events
HSE Summit
Webinars
CME/CE
Resources
PBMI Innovators
Emerging Leaders
Interactive Tools
Sponsored Content
PBM Directory
Commentaries
Subscribe
My Account
News
Watch
Conferences
Partners
Publications
Events
CME/CE
Resources
PBM Directory
Commentaries
Subscribe
ADHD
Acute Pain
Asthma
Atrial Fibrillation
Autoimmune Diseases
Biologics
Biosimilars
Blood Cancer
Breast Cancer
Bronchiectasis
COVID-19
Cardiovascular Diseases
Depression
Dermatology
Digital Health
Drug Coverage
Duchenne Muscular Dystrophy
Eyecare
FDA
Friedreich Ataxia
Gene Therapy
Graft Versus Host Disease
HIV
Health Systems
Heart Failure
Hemophilia
Hidradenitis Suppurativa
Hypertrophic Cardiomyopathy (HCM)
Infectious Disease
Leukemia and Lymphoma
Liver Disease
Lung Cancer
Mental Health
Metabolic Dysfunction-Associated Steatohepatitis
Multiple Sclerosis
NSCLC
Neonatal Care
Nephrology
Obstetrics-Gynecology & Women's Health
Oncology
Oncology Biomarkers
Opioids
PTSD
Pediatrics
Plaque Psoriasis
Population Health
Post-Acute Care
Prescription Digital Therapeutics
Pulmonary Arterial Hypertension
RSV
Reproductive Health
Respiratory Conditions
Safety & Recalls
Schizophrenia
Shingles
Skin Cancer
Sleep Disorders
Solid Tumors
Spinal Muscular Atrophy
Substance Use Disorder
The Improving Patient Access Podcast
Type 2 Diabetes
Type I Diabetes
Type II Inflammation
Ulcerative Colitis
Uro-Oncology
Urothelial Carcinoma
Vaccines
Women's Health
Year in Review- Dermatology
Choose Topic
Spotlight -
AMCP Nexus 2026
|
State of the Industry survey: Share your 2027 outlook
|
HSES 2026
Advertisement
New Insights Into ADHD
New Insights Into ADHD
June 3rd 2026
An in-depth look into current treatments of ADHD.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
CVS Health is splitting in two, according to news reports
2
On Medicaid cuts, the Medicare Advantage market, commercial insurance and the future of U.S. health insurance: A conversation with Geisinger's Jeremy Gaskill
3
The CVS Health split. How separate will the two companies really be?
4
A Democratic Congress likely means more oversight for payers, not a Medicaid rollback
5
Jeremy Gaskill on moving from Humana to Geisinger Health Plan